ARCHIVES

FDA Approves Abraxane And Alimta for NSCLC

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

DCE Advisers Okay Cooperative Agreements For Epidemiolgic Of Esophageal Cancers

March 29, 1991

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010